MDCO - The Medicines Company (MDCO) CEO Mark Timney on Q4 2018 Results - Earnings Call Transcript
The Medicines Company (MDCO)
Q4 2018 Results Earnings Conference Call
February 27, 2019, 08:30 AM ET
Company Participants
Krishna Gorti - VP, IR
Mark Timney - CEO
Christopher Visioli - CFO
Peter Wijngaard - CDO
Conference Call Participants
Jessica Fye - JPMorgan
Umer Raffat - Evercore ISI
Chris Shibutani - Cowen
Adnan Butt - Guggenheim Securities
Biren Amin - Jefferies
Paul Choi - Goldman Sachs
Joel Beatty - Citi
Jay Olson - Oppenheimer
Akash Tewari - Wolfe Research
Mayank Mamtani - B. Riley FBR
Presentation
Operator
Greetings, and welcome to The Medicines Company Fourth Quarter